Dr. Jiang Jiandong obtained his M.D. degree in the Fudan University Shanghai School of Medicine (1988). He then spent 10 years in the Department of Medicine at the Mount Sinai Hospital in New York. Dr. Jiang came back to China in 1999 and worked as the director of the Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CAMS) / Peking Union Medical College (PUMC) from 1999 to 2010. As the Academician of Chinese Academy of Engineering, Dr. Jiang is currently the president of the Institutes of Pharmaceutical Sciences as well as director of the Institute of Materia Medica, CAMS / PUMC. In addition, he serves as the Chair of Department of Pharmacology in PUMC, and Editor-in-Chief for the Journal of Acta Pharmaceutica Sinica. Dr. Jiang’s research focuses on the drug R&D covers infectious diseases, cancer and metabolic disorders. Dr. Jiang holds more than 20 approved patents and has published over 200 original articles in SCI-listed journals like Nature, Nature Medicine, Cancer Cell, Hepatology, PNAS et al. Two accomplishments of innovative drug research have been translated into clinical use, with one for the treatment of drug-resistant hepatitis B and one for treating metabolic syndromes. He has received two National Awards in China for his contribution in drug discovery.